Siemens targets molecular imaging in research pact:
This article was originally published in Clinica
In a deal that signifies its investment in molecular imaging, Siemens Medical Solutions has agreed to dedicate resources, researchers and technology to the Center for Molecular Imaging Research (CMIR) at Massachusetts General Hospital. The CMIR focuses on combining genetic information and new chemistries to develop imaging probes, which are detectable by imaging technologies, to study diseases, such as cancer, atherosclerosis and rheumatoid arthritis. "The long-term goals of the collaboration are to develop novel technologies for in vivo sensing and imaging of molecular events, and to expand these new tools into clinical applications," says Dr Ralph Weissleder, the CMIR's director.